Clinical Trial Update: Role of SAMITAL® in the Relief of Chemo-radiation (CT-RT) Induced Oral Mucositis in Head and Neck Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating SAMITAL® for relief of chemo-radiation–induced oral mucositis in head and neck cancer patients has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Oral Mucositis

Drugs mentioned

• SAMITAL®

Snippet

Sponsor: Istituto Oncologico Veneto IRCCS | Conditions: Head-and-neck Squamous Cell Carcinoma, Oral Mucositis | Phase 2 | Status: COMPLETED